MBX Biosciences, Inc. (MBX)
MBX Biosciences, Inc. (MBX) has a 8-report earnings history dating back to Nov 07, 2024. Its average absolute post-earnings move is ±5.01%, and 62.5% of those reactions were positive. Its largest post-earnings gain was +17.66% (May 07, 2026) and its largest decline was -4.63% (Aug 07, 2025). The next earnings report is predicted for 2026-11-06 (estimated).
Earnings reactions
How MBX moved on each past earnings report.
Earnings Impact
Total Earnings
8
Avg Abs. Movement
±5.01%
Positive %
62.5%
Negative %
37.5%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 06, 2026 | ☀ PRE | -0.61% | open_in_new |
| May 07, 2026 | ☽ POST | +17.66% | open_in_new |
| Mar 12, 2026 | ☀ PRE | -3.42% | open_in_new |
| Nov 06, 2025 | ☀ PRE | +9.71% | open_in_new |
Earnings Count
8
Total earnings in dataset
Avg Abs. Movement
±5.01%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260827 | open_in_new SEC.gov |
| 144 | 20260817 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260810 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260810 | open_in_new SEC.gov |
| 10-Q | 20260806 | open_in_new SEC.gov |
| 8-K | 20260806 | open_in_new SEC.gov |
| 4 | 20260805 | open_in_new SEC.gov |
| 144 | 20260804 | open_in_new SEC.gov |
| 144 | 20260804 | open_in_new SEC.gov |
Frequently asked about MBX earnings
When does MBX Biosciences, Inc. report earnings next? expand_more
MBX Biosciences, Inc. (MBX)'s next earnings date is estimated for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does MBX stock move after earnings? expand_more
Over 8 reports, MBX has moved an average of ±5.01% the session after earnings, closing higher 62.5% of the time.
What was MBX's biggest post-earnings move? expand_more
MBX's largest post-earnings gain on record was +17.66% on May 07, 2026, and its largest decline was -4.63% on Aug 07, 2025.
Where can I find MBX Biosciences, Inc.'s SEC filings? expand_more
All of MBX Biosciences, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right